XML 80 R66.htm IDEA: XBRL DOCUMENT v2.4.1.9
Equity Method Investments Narrative (Detail) (USD $)
3 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 22, 2014
Sep. 30, 2014
Schedule of Equity Method Investments [Line Items]        
Equity in earnings (losses) of equity method investments $ (532,000)us-gaap_IncomeLossFromEquityMethodInvestments $ 749,000us-gaap_IncomeLossFromEquityMethodInvestments    
Equity method investments 27,197,000us-gaap_EquityMethodInvestments   2,500,000us-gaap_EquityMethodInvestments 28,944,000us-gaap_EquityMethodInvestments
Debt Conversion, Converted instrument, rate 9.00%us-gaap_DebtConversionConvertedInstrumentRate      
Equity method investment, additional financing     2,500,000brks_EquityMethodInvestmentAdditionalFinancing  
BioCision, LLC        
Schedule of Equity Method Investments [Line Items]        
Joint venture interest, percentage 22.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_BioCisionLLCMember
     
Investment cost 4,000,000us-gaap_EquityMethodInvestmentAggregateCost
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_BioCisionLLCMember
     
Equity in earnings (losses) of equity method investments (200,000)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_BioCisionLLCMember
     
Equity method investments 3,500,000us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_BioCisionLLCMember
     
ULVAC Cryogenics, Inc.        
Schedule of Equity Method Investments [Line Items]        
Joint venture interest, percentage 50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_UlvacCryogenicsIncorporatedMember
     
Equity in earnings (losses) of equity method investments 300,000us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_UlvacCryogenicsIncorporatedMember
800,000us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_UlvacCryogenicsIncorporatedMember
   
Equity method investments 21,900,000us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_UlvacCryogenicsIncorporatedMember
     
Management fee payments received 200,000us-gaap_ManagementFeesRevenue
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_UlvacCryogenicsIncorporatedMember
     
Charges incurred from related parties 100,000us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_UlvacCryogenicsIncorporatedMember
     
Accounts payable for unpaid products and services 61,000us-gaap_DueToAffiliateCurrentAndNoncurrent
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_UlvacCryogenicsIncorporatedMember
    79,000us-gaap_DueToAffiliateCurrentAndNoncurrent
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_UlvacCryogenicsIncorporatedMember
Yaskawa Brooks Automation, Inc.        
Schedule of Equity Method Investments [Line Items]        
Joint venture interest, percentage 50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
     
Equity method investment, other than temporary impairment 700,000us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
     
Equity in earnings (losses) of equity method investments (700,000)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
(18,000)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
   
Equity method investments 1,700,000us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
     
Charges incurred from related parties 400,000us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
100,000us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
   
Accounts payable for unpaid products and services 100,000us-gaap_DueToAffiliateCurrentAndNoncurrent
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
     
Revenues earned from joint ventures 1,100,000us-gaap_RevenueFromRelatedParties
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
700,000us-gaap_RevenueFromRelatedParties
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
   
Due from joint venture $ 1,500,000us-gaap_DueFromJointVentures
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember
    $ 2,100,000us-gaap_DueFromJointVentures
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= brks_YaskawaBrooksAutomationIncMember